Expertise

Dr. Kuhn is a Professor at USC, the director of USC’s CSI-Cancer Institute. His vision of translating innovation in research to meaningful products for patient care is driving his everyday efforts. He also serves as Dean’s Professor of Biological Sciences, Professor of Medicine, Aerospace & Mechanical Engineering, and Biomedical Engineering at USC as well as Director of the USC Michelson Convergent Science Institute in Cancer (CSI-Cancer) and the deputy director of the Convergent Science – Virtual Cancer Center. He holds a chair as Honorary Professor of Cancer Science at the University of Manchester in the United Kingdom. Dr. Kuhn is a physicist who trained initially at the Julius Maximilians Universität Würzburg, Germany, before receiving his Masters in Physics at the University of Albany. Previously, Dr. Kuhn held a faculty appointment at Stanford where he established the structural genomics research enterprise and focused his research on technology developments in structural biology that were utilized by breakthrough research such as Dr. Roger Kornberg’s (Nobel prize 2006) structure determination of the RNA Polymerase. Dr. Kuhn joined Scripps and established the Physics Oncology program where he advanced technologies that led to the structure determination of the human b2AR GPCR with collaborators including Dr. Brian Kobilka (Nobel prize 2012).

His research and inventions have resulted in over 300 peer-reviewed publications, which have been cited over twenty-thousand times. Technologies developed by Dr. Kuhn have been the foundation of multiple healthcare companies and his research has been licensed to numerous companies.